Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology
(HEARTBEAT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a phase 0, non-interventional, longitudinal, electronic data capture (EDC) study to facilitate the HEARTBEAT Study project has set out to explore the potential use of smartwatches in collecting and analyzing biometric data to improve the detection, identification, and understanding of cardiovascular diseases and related conditions by SAMSUNG and Tulane. The study will include up to ten thousand adult subjects tasked with wearing a smartwatch to collect digital biomarker data over a 1 year period. Concurrent to smartwatch data collection, subjects will be instructed to complete questionnaires via the Huma Decentralized Clinical Trials (HUMADCT) platform. There are no investigational drugs or interventions administered as part of this study.
Who Is on the Research Team?
Nassir Marrouche, MD
Principal Investigator
Tulane University
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Enrollment and Training
Participants are provided with a smartwatch and trained on study procedures, including the use of the wearable device and completion of web-based questionnaires
Data Collection
Participants wear the smartwatch to collect digital biomarker data and complete questionnaires via the HUMADCT platform
Follow-up
Participants return the smartwatch and data is analyzed for patterns indicating cardiovascular risk
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tulane University
Lead Sponsor
Samsung Electronics
Industry Sponsor